With 38 crore people infected India may have reached herd immunity


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ With 38 crore people infected India may have reached herd immunity
The study strongly advocates the fact that a timely lockdown may have reduced the fatality of coronavirus cases in India

A study has claimed that India may have reached herd immunity with about 380 million or 38 crore people already infected.

The detailed study published in the Indian Journal of Medical Research (IJMR) claims to have used susceptible-asymptomatic-infected-recovered (SAIR) model to assess the impact of the lockdown and make predictions on its future course.

“The SAIR model has helped us understand the disease better. If the model is correct, we may have reached herd immunity with about 38 crore people already infected. However, personal protective measures remain crucial,” the authors Manindra Agrawal, Madhuri Kanitkar and M Vidyasagar were quoted in the study as saying.

The study strongly advocates the fact that a timely lockdown may have reduced the fatality of coronavirus cases in India. It also claims that without a lockdown intervention led by the Indian government in the month of March, Covid-19 infections would have peaked by June 2020.

“If there was no lockdown, the number of active infections would have peaked at close to 14.7 million (1.4 crores), resulted in more than 2.6 million (26 lakh) deaths, and the peak would have arrived by June 2020. The number of deaths with the current trends may be less than 0.2 million (2 lakhs),” notes the study.

Method and modelling:

The standard mathematical models could not explain the role of asymptomatic cases in the unfolding of the pandemic, the study noted. A new model was used which was developed on lines of SAIR.

“There is a paucity of data on the behaviour of the virus among the Indian population. Limited testing capability in India at the time of onset of the pandemic, non-availability of standardized tests for serosurveillance and non-availability of data on asymptomatic cases were other limitations. In the current Covid-19 pandemic, a large fraction of the population showed little or no symptoms,” said the study.

Four parameters were used, namely:

Measures the likelihood of the susceptible people getting infected, and denotes recovery rate of patients. The ratio is denoted by R0 (basic reproduction number).

Pandemic progression in India:

The actual data suggested a peak in coronavirus cases in India on September 17, 2020. The model overestimates the actual growth by around 1.5 per cent and the peak arrives four days later. Cumulative deaths are predicted to be around 0.2 million.

The and values for the last phase imply R0 value around 1.39, and the herd immunity for this value of R0 at around 28 per cent of the population in A, I and R categories.

According to the study, around 3.9 million (39 lakh) population was infected or with antibodies at the peak. On September 17, the numbers in I and RI categories were around 5.2 million (52 lakh). Using the 1/ value (=67) of phase 6, the model predicts the total population with infection or antibodies to be around 3.5 million (35 lakh).

Story Source: www.indiatoday.com 

Tags : #IndianJournalofMedicalResearch #HerdImmunity #COVIDAntibody #LatestCOVIDNews23rdOct #Lockdown #FatalityRate #COVID19Pandemic

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026